| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.39e-05 | 180 | 17 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.61e-05 | 187 | 17 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | G protein activity | 1.62e-05 | 59 | 17 | 3 | GO:0003925 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 2.14e-05 | 201 | 17 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | actin binding | 3.79e-05 | 479 | 17 | 5 | GO:0003779 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 4.48e-05 | 12 | 17 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | poly(A)-specific ribonuclease activity | 5.29e-05 | 13 | 17 | 2 | GO:0004535 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 5.59e-05 | 257 | 17 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 1.28e-04 | 20 | 17 | 2 | GO:0017110 | |
| GeneOntologyMolecularFunction | GTPase activity | 1.67e-04 | 341 | 17 | 4 | GO:0003924 | |
| GeneOntologyMolecularFunction | GTP binding | 2.98e-04 | 397 | 17 | 4 | GO:0005525 | |
| GeneOntologyMolecularFunction | spectrin binding | 3.77e-04 | 34 | 17 | 2 | GO:0030507 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 4.22e-04 | 435 | 17 | 4 | GO:0004857 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 4.37e-04 | 439 | 17 | 4 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 4.37e-04 | 439 | 17 | 4 | GO:0019001 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 4.46e-04 | 37 | 17 | 2 | GO:0000175 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 4.59e-04 | 815 | 17 | 5 | GO:0042803 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 5.22e-04 | 40 | 17 | 2 | GO:0016896 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 6.61e-04 | 45 | 17 | 2 | GO:0004532 | |
| GeneOntologyMolecularFunction | lipopolysaccharide binding | 7.52e-04 | 48 | 17 | 2 | GO:0001530 | |
| GeneOntologyMolecularFunction | actin filament binding | 8.76e-04 | 227 | 17 | 3 | GO:0051015 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 9.87e-04 | 55 | 17 | 2 | GO:0051879 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 1.21e-03 | 61 | 17 | 2 | GO:0008408 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.25e-03 | 62 | 17 | 2 | GO:0016796 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 1.37e-03 | 596 | 17 | 4 | GO:0140678 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.78e-03 | 1099 | 17 | 5 | GO:0008092 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 2.67e-03 | 1205 | 17 | 5 | GO:0046983 | |
| GeneOntologyMolecularFunction | exonuclease activity | 2.73e-03 | 92 | 17 | 2 | GO:0004527 | |
| GeneOntologyMolecularFunction | GDP binding | 3.41e-03 | 103 | 17 | 2 | GO:0019003 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 3.58e-03 | 775 | 17 | 4 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 4.75e-03 | 839 | 17 | 4 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 4.77e-03 | 840 | 17 | 4 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.77e-03 | 840 | 17 | 4 | GO:0016818 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 5.86e-03 | 136 | 17 | 2 | GO:0004540 | |
| GeneOntologyMolecularFunction | cytokine binding | 7.73e-03 | 157 | 17 | 2 | GO:0019955 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 8.31e-03 | 163 | 17 | 2 | GO:0031072 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 8.49e-03 | 507 | 17 | 3 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 8.49e-03 | 507 | 17 | 3 | GO:0060589 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.60e-02 | 230 | 17 | 2 | GO:0005516 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.62e-02 | 231 | 17 | 2 | GO:0004518 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.41e-02 | 749 | 17 | 3 | GO:0005509 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 3.97e-11 | 9 | 17 | 4 | GO:0140639 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 3.97e-11 | 9 | 17 | 4 | GO:0051715 | |
| GeneOntologyBiologicalProcess | cytolysis | 1.56e-10 | 12 | 17 | 4 | GO:0019835 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 1.86e-09 | 4 | 17 | 3 | GO:0140973 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 9.29e-09 | 6 | 17 | 3 | GO:0140971 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 2.60e-08 | 8 | 17 | 3 | GO:0140970 | |
| GeneOntologyBiologicalProcess | pyroptotic inflammatory response | 3.47e-08 | 42 | 17 | 4 | GO:0070269 | |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 5.26e-07 | 20 | 17 | 3 | GO:0044406 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammasome-mediated signaling pathway | 1.19e-06 | 26 | 17 | 3 | GO:0141087 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 1.99e-06 | 114 | 17 | 4 | GO:0071346 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 3.26e-06 | 129 | 17 | 4 | GO:0141061 | |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 3.26e-06 | 129 | 17 | 4 | GO:0031640 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 3.58e-06 | 132 | 17 | 4 | GO:0141060 | |
| GeneOntologyBiologicalProcess | defense response to protozoan | 4.17e-06 | 39 | 17 | 3 | GO:0042832 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 4.65e-06 | 141 | 17 | 4 | GO:0034341 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-beta | 4.86e-06 | 41 | 17 | 3 | GO:0035458 | |
| GeneOntologyBiologicalProcess | response to protozoan | 5.23e-06 | 42 | 17 | 3 | GO:0001562 | |
| GeneOntologyBiologicalProcess | defense response to virus | 6.39e-06 | 342 | 17 | 5 | GO:0051607 | |
| GeneOntologyBiologicalProcess | regulation of inflammasome-mediated signaling pathway | 7.86e-06 | 48 | 17 | 3 | GO:0141085 | |
| GeneOntologyBiologicalProcess | response to interferon-beta | 7.86e-06 | 48 | 17 | 3 | GO:0035456 | |
| GeneOntologyBiologicalProcess | inflammasome-mediated signaling pathway | 1.06e-05 | 53 | 17 | 3 | GO:0141084 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response | 1.61e-05 | 193 | 17 | 4 | GO:0050729 | |
| GeneOntologyBiologicalProcess | response to virus | 1.83e-05 | 425 | 17 | 5 | GO:0009615 | |
| GeneOntologyBiologicalProcess | positive regulation of pattern recognition receptor signaling pathway | 3.54e-05 | 79 | 17 | 3 | GO:0062208 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | 4.77e-05 | 519 | 17 | 5 | GO:0045088 | |
| GeneOntologyBiologicalProcess | cell killing | 9.83e-05 | 307 | 17 | 4 | GO:0001906 | |
| GeneOntologyBiologicalProcess | cellular response to lipopolysaccharide | 1.13e-04 | 318 | 17 | 4 | GO:0071222 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | 1.31e-04 | 643 | 17 | 5 | GO:0002831 | |
| GeneOntologyBiologicalProcess | cellular response to molecule of bacterial origin | 1.33e-04 | 332 | 17 | 4 | GO:0071219 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 1.34e-04 | 333 | 17 | 4 | GO:0002218 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 1.52e-04 | 129 | 17 | 3 | GO:0039531 | |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 1.89e-04 | 364 | 17 | 4 | GO:0071216 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 2.38e-04 | 150 | 17 | 3 | GO:0050830 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 2.85e-04 | 405 | 17 | 4 | GO:0042742 | |
| GeneOntologyBiologicalProcess | positive regulation of viral genome replication | 2.93e-04 | 31 | 17 | 2 | GO:0045070 | |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | 3.27e-04 | 420 | 17 | 4 | GO:0045089 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 3.33e-04 | 33 | 17 | 2 | GO:0000289 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | 4.28e-04 | 451 | 17 | 4 | GO:0002833 | |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 4.61e-04 | 188 | 17 | 3 | GO:0002753 | |
| GeneOntologyBiologicalProcess | response to lipopolysaccharide | 4.77e-04 | 464 | 17 | 4 | GO:0032496 | |
| GeneOntologyBiologicalProcess | regulation of pattern recognition receptor signaling pathway | 4.98e-04 | 193 | 17 | 3 | GO:0062207 | |
| GeneOntologyBiologicalProcess | response to molecule of bacterial origin | 5.90e-04 | 491 | 17 | 4 | GO:0002237 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response | 7.06e-04 | 515 | 17 | 4 | GO:0050727 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex assembly | 7.98e-04 | 227 | 17 | 3 | GO:0031334 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 8.08e-04 | 228 | 17 | 3 | GO:0051701 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | 8.65e-04 | 967 | 17 | 5 | GO:0071345 | |
| GeneOntologyBiologicalProcess | regulation of defense response | 1.03e-03 | 1006 | 17 | 5 | GO:0031347 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response | 1.16e-03 | 589 | 17 | 4 | GO:0031349 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.29e-03 | 65 | 17 | 2 | GO:0000288 | |
| GeneOntologyBiologicalProcess | activation of immune response | 1.43e-03 | 623 | 17 | 4 | GO:0002253 | |
| GeneOntologyBiologicalProcess | response to cytokine | 1.44e-03 | 1083 | 17 | 5 | GO:0034097 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 1.45e-03 | 1085 | 17 | 5 | GO:0050776 | |
| GeneOntologyBiologicalProcess | positive regulation of viral process | 1.45e-03 | 69 | 17 | 2 | GO:0048524 | |
| GeneOntologyBiologicalProcess | innate immune response | 1.49e-03 | 1092 | 17 | 5 | GO:0045087 | |
| GeneOntologyBiologicalProcess | response to peptide | 1.54e-03 | 1100 | 17 | 5 | GO:1901652 | |
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 1.68e-03 | 294 | 17 | 3 | GO:0002221 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 1.99e-03 | 312 | 17 | 3 | GO:0002758 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 2.51e-03 | 91 | 17 | 2 | GO:0045069 | |
| GeneOntologyBiologicalProcess | positive regulation of response to external stimulus | 2.67e-03 | 738 | 17 | 4 | GO:0032103 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 2.78e-03 | 351 | 17 | 3 | GO:0044403 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 2.80e-03 | 748 | 17 | 4 | GO:0071396 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | 3.08e-03 | 1286 | 17 | 5 | GO:0140546 | |
| GeneOntologyBiologicalProcess | protein targeting | 3.30e-03 | 373 | 17 | 3 | GO:0006605 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 3.40e-03 | 1316 | 17 | 5 | GO:0032101 | |
| GeneOntologyBiologicalProcess | miRNA-mediated gene silencing by mRNA destabilization | 3.57e-03 | 109 | 17 | 2 | GO:0035279 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 4.34e-03 | 845 | 17 | 4 | GO:0050778 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 4.49e-03 | 416 | 17 | 3 | GO:0030522 | |
| GeneOntologyBiologicalProcess | defense response to other organism | 4.54e-03 | 1407 | 17 | 5 | GO:0098542 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 5.19e-03 | 132 | 17 | 2 | GO:0000956 | |
| GeneOntologyBiologicalProcess | viral genome replication | 5.58e-03 | 137 | 17 | 2 | GO:0019079 | |
| GeneOntologyBiologicalProcess | response to bacterium | 5.79e-03 | 916 | 17 | 4 | GO:0009617 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 7.03e-03 | 489 | 17 | 3 | GO:0043254 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 7.17e-03 | 156 | 17 | 2 | GO:1903900 | |
| GeneOntologyBiologicalProcess | inflammatory response | 9.12e-03 | 1043 | 17 | 4 | GO:0006954 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 9.85e-03 | 553 | 17 | 3 | GO:0002757 | |
| GeneOntologyBiologicalProcess | regulation of viral process | 1.01e-02 | 186 | 17 | 2 | GO:0050792 | |
| GeneOntologyCellularComponent | host cell part | 8.92e-09 | 6 | 17 | 3 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 8.92e-09 | 6 | 17 | 3 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 8.92e-09 | 6 | 17 | 3 | GO:0033655 | |
| GeneOntologyCellularComponent | host intracellular region | 8.92e-09 | 6 | 17 | 3 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 8.92e-09 | 6 | 17 | 3 | GO:0030430 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 8.92e-09 | 6 | 17 | 3 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 8.92e-09 | 6 | 17 | 3 | GO:0020005 | |
| GeneOntologyCellularComponent | symbiont cell surface | 2.50e-08 | 8 | 17 | 3 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 3.74e-08 | 9 | 17 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | host cellular component | 2.02e-07 | 15 | 17 | 3 | GO:0018995 | |
| GeneOntologyCellularComponent | CCR4-NOT core complex | 9.32e-06 | 6 | 17 | 2 | GO:0030015 | |
| GeneOntologyCellularComponent | CCR4-NOT complex | 7.42e-05 | 16 | 17 | 2 | GO:0030014 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 6.95e-04 | 934 | 17 | 5 | GO:0048471 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.02e-03 | 576 | 17 | 4 | GO:0015629 | |
| GeneOntologyCellularComponent | P-body | 3.06e-03 | 102 | 17 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | vesicle membrane | 3.31e-03 | 1325 | 17 | 5 | GO:0012506 | |
| GeneOntologyCellularComponent | neuromuscular junction | 3.67e-03 | 112 | 17 | 2 | GO:0031594 | |
| GeneOntologyCellularComponent | actin filament | 6.15e-03 | 146 | 17 | 2 | GO:0005884 | |
| MousePheno | increased susceptibility to parasitic infection induced morbidity/mortality | 7.61e-05 | 11 | 17 | 2 | MP:0010750 | |
| Domain | GBP_C | 9.83e-11 | 10 | 17 | 4 | PF02841 | |
| Domain | Guanylate-bd_C | 1.54e-10 | 11 | 17 | 4 | IPR003191 | |
| Domain | GBP | 1.54e-10 | 11 | 17 | 4 | PF02263 | |
| Domain | G_GB1_RHD3_dom | 1.54e-10 | 11 | 17 | 4 | IPR030386 | |
| Domain | Guanylate-bd_N | 1.54e-10 | 11 | 17 | 4 | IPR015894 | |
| Domain | G_GB1_RHD3 | 1.54e-10 | 11 | 17 | 4 | PS51715 | |
| Domain | RNase_CAF1 | 7.79e-06 | 5 | 17 | 2 | IPR006941 | |
| Domain | CAF1 | 7.79e-06 | 5 | 17 | 2 | PF04857 | |
| Domain | P-loop_NTPase | 7.47e-04 | 848 | 17 | 5 | IPR027417 | |
| Domain | - | 8.23e-04 | 47 | 17 | 2 | 3.30.420.10 | |
| Domain | RNaseH-like_dom | 1.76e-03 | 69 | 17 | 2 | IPR012337 | |
| Domain | - | 3.96e-03 | 746 | 17 | 4 | 3.40.50.300 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.50e-06 | 98 | 13 | 4 | M965 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 8.57e-05 | 273 | 13 | 4 | M983 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 1.19e-04 | 18 | 13 | 2 | MM15336 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 1.63e-04 | 21 | 13 | 2 | M27634 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 2.14e-04 | 24 | 13 | 2 | MM15090 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 2.33e-04 | 25 | 13 | 2 | M13492 | |
| Pathway | REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS | 4.08e-04 | 33 | 13 | 2 | M48026 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 4.33e-04 | 34 | 13 | 2 | MM15325 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 9.01e-04 | 49 | 13 | 2 | M27614 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 1.09e-03 | 54 | 13 | 2 | MM15089 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 1.18e-03 | 56 | 13 | 2 | M839 | |
| Pathway | KEGG_RNA_DEGRADATION | 1.30e-03 | 59 | 13 | 2 | M963 | |
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 2.73e-12 | 8 | 17 | 4 | 16689661 | |
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 4.91e-12 | 9 | 17 | 4 | 24739961 | |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 1.29e-11 | 11 | 17 | 4 | 24715728 | |
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 1.29e-11 | 11 | 17 | 4 | 18025219 | |
| Pubmed | 1.93e-11 | 12 | 17 | 4 | 35906252 | ||
| Pubmed | A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. | 1.51e-10 | 19 | 17 | 4 | 21551061 | |
| Pubmed | 3.88e-10 | 4 | 17 | 3 | 38404575 | ||
| Pubmed | Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection. | 9.69e-10 | 5 | 17 | 3 | 31964735 | |
| Pubmed | 9.69e-10 | 5 | 17 | 3 | 21151871 | ||
| Pubmed | 9.69e-10 | 5 | 17 | 3 | 12396730 | ||
| Pubmed | Unique features of different members of the human guanylate-binding protein family. | 9.69e-10 | 5 | 17 | 3 | 17266443 | |
| Pubmed | Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. | 8.13e-09 | 9 | 17 | 3 | 33479228 | |
| Pubmed | IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes. | 1.60e-08 | 11 | 17 | 3 | 27693356 | |
| Pubmed | 2.13e-08 | 12 | 17 | 3 | 29459437 | ||
| Pubmed | 4.40e-08 | 15 | 17 | 3 | 17114464 | ||
| Pubmed | 4.40e-08 | 15 | 17 | 3 | 25774716 | ||
| Pubmed | 6.57e-08 | 17 | 17 | 3 | 25774715 | ||
| Pubmed | Interferon inducible GBPs restrict Burkholderia thailandensis motility induced cell-cell fusion. | 1.10e-07 | 20 | 17 | 3 | 32150572 | |
| Pubmed | 1.28e-07 | 21 | 17 | 3 | 19158679 | ||
| Pubmed | 2.22e-07 | 25 | 17 | 3 | 35139355 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19605561 | ||
| Pubmed | Genetic Regulation of Guanylate-Binding Proteins 2b and 5 during Leishmaniasis in Mice. | 2.25e-07 | 2 | 17 | 2 | 29467757 | |
| Pubmed | Conservation of the deadenylase activity of proteins of the Caf1 family in human. | 2.25e-07 | 2 | 17 | 2 | 15769875 | |
| Pubmed | CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex. | 2.25e-07 | 2 | 17 | 2 | 35248544 | |
| Pubmed | Structural basis for GTP-induced dimerization and antiviral function of guanylate-binding proteins. | 2.25e-07 | 2 | 17 | 2 | 33876762 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 30062052 | ||
| Pubmed | Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | 6.74e-07 | 3 | 17 | 2 | 36639389 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 31091448 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 11726669 | ||
| Pubmed | GTPase properties of the interferon-induced human guanylate-binding protein 2. | 6.74e-07 | 3 | 17 | 2 | 8706832 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25944446 | ||
| Pubmed | CCR4-NOT deadenylates mRNA associated with RNA-induced silencing complexes in human cells. | 6.74e-07 | 3 | 17 | 2 | 20065043 | |
| Pubmed | GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. | 6.74e-07 | 3 | 17 | 2 | 38636926 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 16914101 | ||
| Pubmed | The CCR4-NOT complex suppresses untimely translational activation of maternal mRNAs. | 6.74e-07 | 3 | 17 | 2 | 37767629 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 15717119 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 32620042 | ||
| Pubmed | [Guanylate-binding protein 2 regulates the maturation of mouse dendritic cells induced by β-glucan]. | 6.74e-07 | 3 | 17 | 2 | 29089068 | |
| Pubmed | GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. | 6.74e-07 | 3 | 17 | 2 | 35780181 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 26416908 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 33021411 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 35383115 | ||
| Pubmed | Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. | 6.74e-07 | 3 | 17 | 2 | 23248289 | |
| Pubmed | GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis. | 6.74e-07 | 3 | 17 | 2 | 29128363 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 1715024 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 27605379 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 32354743 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 20950129 | ||
| Pubmed | Two families of GTPases dominate the complex cellular response to IFN-gamma. | 6.74e-07 | 3 | 17 | 2 | 9862701 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 22730319 | ||
| Pubmed | Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. | 1.35e-06 | 4 | 17 | 2 | 7823961 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 10386861 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 11136725 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 9820826 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 11747467 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 20595394 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 36609599 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 39337476 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 8917111 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 23236473 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 22977175 | ||
| Pubmed | TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2. | 2.25e-06 | 5 | 17 | 2 | 30858199 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 35390160 | ||
| Pubmed | Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase. | 2.25e-06 | 5 | 17 | 2 | 21336257 | |
| Pubmed | Murine GBP-2: a new IFN-gamma-induced member of the GBP family of GTPases isolated from macrophages. | 2.25e-06 | 5 | 17 | 2 | 9858320 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 31924127 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 17293456 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 21757726 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 20595389 | ||
| Pubmed | hCAF1, a new regulator of PRMT1-dependent arginine methylation. | 3.37e-06 | 6 | 17 | 2 | 17264152 | |
| Pubmed | CNOT7/hCAF1 is involved in ICAM-1 and IL-8 regulation by tristetraprolin. | 3.37e-06 | 6 | 17 | 2 | 25038453 | |
| Pubmed | Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits. | 4.72e-06 | 7 | 17 | 2 | 10637334 | |
| Pubmed | TRIF signaling is required for caspase-11-dependent immune responses and lethality in sepsis. | 4.72e-06 | 7 | 17 | 2 | 30587103 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 21502320 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 20505078 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 21078877 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 21741365 | ||
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 1.01e-05 | 10 | 17 | 2 | 28334111 | |
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 17452450 | ||
| Pubmed | Human Ccr4-Not complexes contain variable deadenylase subunits. | 1.48e-05 | 12 | 17 | 2 | 19558367 | |
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 31320642 | ||
| Pubmed | 2.04e-05 | 14 | 17 | 2 | 20584987 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 2.35e-05 | 15 | 17 | 2 | 21981923 | |
| Pubmed | 3.42e-05 | 18 | 17 | 2 | 27001747 | ||
| Pubmed | RNF219 attenuates global mRNA decay through inhibition of CCR4-NOT complex-mediated deadenylation. | 4.25e-05 | 20 | 17 | 2 | 34887419 | |
| Pubmed | BTG4 is a meiotic cell cycle-coupled maternal-zygotic-transition licensing factor in oocytes. | 6.17e-05 | 24 | 17 | 2 | 27065194 | |
| Pubmed | 6.43e-05 | 162 | 17 | 3 | 23012479 | ||
| Pubmed | 9.06e-05 | 29 | 17 | 2 | 33278357 | ||
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 1.18e-04 | 33 | 17 | 2 | 20551175 | |
| Pubmed | 2.01e-04 | 43 | 17 | 2 | 30733279 | ||
| Pubmed | Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. | 2.20e-04 | 45 | 17 | 2 | 23663784 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 2.93e-04 | 271 | 17 | 3 | 25737280 | |
| Interaction | GBP1 interactions | 5.61e-06 | 42 | 17 | 3 | int:GBP1 | |
| Interaction | GBP2 interactions | 1.20e-05 | 54 | 17 | 3 | int:GBP2 | |
| Interaction | GBP7 interactions | 1.87e-05 | 8 | 17 | 2 | int:GBP7 | |
| Interaction | GBP3 interactions | 3.00e-05 | 10 | 17 | 2 | int:GBP3 | |
| Interaction | TOB2 interactions | 1.26e-04 | 20 | 17 | 2 | int:TOB2 | |
| Interaction | NANOS1 interactions | 1.26e-04 | 20 | 17 | 2 | int:NANOS1 | |
| Interaction | FANCD2OS interactions | 2.15e-04 | 26 | 17 | 2 | int:FANCD2OS | |
| Interaction | NANOS2 interactions | 2.15e-04 | 26 | 17 | 2 | int:NANOS2 | |
| Interaction | TEX13A interactions | 2.32e-04 | 27 | 17 | 2 | int:TEX13A | |
| Interaction | CPEB1 interactions | 2.35e-04 | 146 | 17 | 3 | int:CPEB1 | |
| Interaction | BTG2 interactions | 2.68e-04 | 29 | 17 | 2 | int:BTG2 | |
| Interaction | BTG1 interactions | 2.87e-04 | 30 | 17 | 2 | int:BTG1 | |
| Interaction | UNK interactions | 3.20e-04 | 408 | 17 | 4 | int:UNK | |
| Interaction | KLHL4 interactions | 3.48e-04 | 33 | 17 | 2 | int:KLHL4 | |
| Interaction | GADD45B interactions | 3.92e-04 | 35 | 17 | 2 | int:GADD45B | |
| Interaction | PABPN1L interactions | 4.62e-04 | 38 | 17 | 2 | int:PABPN1L | |
| Interaction | TOB1 interactions | 6.21e-04 | 44 | 17 | 2 | int:TOB1 | |
| Interaction | MMP7 interactions | 6.78e-04 | 46 | 17 | 2 | int:MMP7 | |
| Interaction | ANKRD17 interactions | 8.43e-04 | 226 | 17 | 3 | int:ANKRD17 | |
| Interaction | CNOT6 interactions | 1.00e-03 | 56 | 17 | 2 | int:CNOT6 | |
| Cytoband | 1p22.2 | 2.62e-10 | 28 | 17 | 4 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 1.75e-07 | 137 | 17 | 4 | chr1p22 | |
| GeneFamily | CCR4-NOT transcription complex | 1.51e-05 | 11 | 10 | 2 | 1023 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 2.84e-08 | 145 | 17 | 5 | MM3744 | |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_UP | 2.32e-05 | 87 | 17 | 3 | MM1253 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 3.32e-05 | 98 | 17 | 3 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 3.52e-05 | 100 | 17 | 3 | MM458 | |
| Coexpression | HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 3.59e-05 | 14 | 17 | 2 | M41166 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL | 7.02e-05 | 126 | 17 | 3 | M45721 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 8.25e-05 | 21 | 17 | 2 | MM651 | |
| Coexpression | GREENBAUM_E2A_TARGETS_DN | 9.08e-05 | 22 | 17 | 2 | MM635 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 9.20e-05 | 138 | 17 | 3 | MM1047 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 1.18e-04 | 25 | 17 | 2 | MM672 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP | 1.28e-04 | 26 | 17 | 2 | M41741 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 1.32e-04 | 156 | 17 | 3 | MM3763 | |
| Coexpression | HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 1.40e-04 | 159 | 17 | 3 | M40998 | |
| Coexpression | GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP | 1.51e-04 | 163 | 17 | 3 | M8663 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN | 1.70e-04 | 170 | 17 | 3 | M6852 | |
| Coexpression | GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 1.70e-04 | 170 | 17 | 3 | M6846 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN | 1.83e-04 | 174 | 17 | 3 | M6769 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 1.89e-04 | 176 | 17 | 3 | MM1048 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 1.92e-04 | 177 | 17 | 3 | M8666 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN | 2.07e-04 | 33 | 17 | 2 | M41194 | |
| Coexpression | XIE_ST_HSC_S1PR3_OE_UP | 2.33e-04 | 189 | 17 | 3 | M41755 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP | 2.33e-04 | 189 | 17 | 3 | M9722 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN | 2.48e-04 | 193 | 17 | 3 | M4284 | |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN | 2.63e-04 | 197 | 17 | 3 | M3338 | |
| Coexpression | GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN | 2.63e-04 | 197 | 17 | 3 | M4720 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 2.67e-04 | 198 | 17 | 3 | MM17083 | |
| Coexpression | GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 2.71e-04 | 199 | 17 | 3 | M8380 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP | 2.71e-04 | 199 | 17 | 3 | M3439 | |
| Coexpression | GSE17721_CTRL_VS_LPS_24H_BMDC_DN | 2.75e-04 | 200 | 17 | 3 | M3704 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP | 2.75e-04 | 200 | 17 | 3 | M5979 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 2.75e-04 | 200 | 17 | 3 | M9358 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN | 2.75e-04 | 200 | 17 | 3 | M5808 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_8_PRECICTIVE_ICB_RESPONSE | 2.75e-04 | 200 | 17 | 3 | MM17082 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 2.75e-04 | 200 | 17 | 3 | M6092 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN | 2.75e-04 | 200 | 17 | 3 | M7807 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | 2.97e-04 | 973 | 17 | 5 | M41080 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_31 | 3.13e-04 | 209 | 17 | 3 | MM17088 | |
| Coexpression | HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 3.36e-04 | 42 | 17 | 2 | M41024 | |
| Coexpression | HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 4.19e-04 | 231 | 17 | 3 | M40995 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 4.41e-04 | 235 | 17 | 3 | MM978 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.15e-04 | 52 | 17 | 2 | MM1118 | |
| Coexpression | DANG_REGULATED_BY_MYC_DN | 5.34e-04 | 251 | 17 | 3 | M2310 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 6.39e-04 | 267 | 17 | 3 | MM1091 | |
| Coexpression | DELASERNA_MYOD_TARGETS_DN | 6.63e-04 | 59 | 17 | 2 | MM659 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 6.68e-04 | 271 | 17 | 3 | MM1075 | |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 6.85e-04 | 60 | 17 | 2 | M1515 | |
| Coexpression | MIKKELSEN_NPC_LCP_WITH_H3K4ME3 | 7.32e-04 | 62 | 17 | 2 | MM865 | |
| Coexpression | BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP | 7.80e-04 | 286 | 17 | 3 | M34008 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | 8.57e-04 | 1226 | 17 | 5 | MM979 | |
| Coexpression | MAHAJAN_RESPONSE_TO_IL1A_DN | 9.32e-04 | 70 | 17 | 2 | M12107 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 1.34e-03 | 84 | 17 | 2 | MM1049 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 1.47e-03 | 88 | 17 | 2 | MM1087 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP | 1.47e-03 | 88 | 17 | 2 | M19695 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP | 1.57e-03 | 91 | 17 | 2 | M41042 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K3 | 3.37e-05 | 240 | 17 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K3 | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 1.19e-07 | 122 | 17 | 4 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 2.01e-07 | 139 | 17 | 4 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.63e-07 | 161 | 17 | 4 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-07 | 177 | 17 | 4 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-07 | 177 | 17 | 4 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-07 | 177 | 17 | 4 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-07 | 178 | 17 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-07 | 180 | 17 | 4 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-07 | 182 | 17 | 4 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-07 | 187 | 17 | 4 | 7abc174a06bf07b5f6efe0a370fbb1c23e0079b3 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-07 | 187 | 17 | 4 | b0a2e417b4eb9a185033e89c5df3431c11488688 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-07 | 187 | 17 | 4 | f9863428943b695f26bd680e6fc5aeb38ec3422f | |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 7.48e-07 | 193 | 17 | 4 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | Sepsis-Leuk-UTI|Sepsis / Disease, condition lineage and cell class | 8.62e-07 | 200 | 17 | 4 | 7d92b24c0c888dd46e40b7e3c6c2645c3604f132 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-05 | 115 | 17 | 3 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-05 | 126 | 17 | 3 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.56e-05 | 130 | 17 | 3 | 04ad0542210e7a8c8d4d9d0bfd83de2629bc3176 | |
| ToppCell | Myeloid-F|World / shred on cell class and cell subclass (v4) | 2.58e-05 | 154 | 17 | 3 | 6d53eec4aefe54836bbfd314f28f5e9a24c2d833 | |
| ToppCell | Myeloid-Myeloid-F|Myeloid / shred on cell class and cell subclass (v4) | 2.68e-05 | 156 | 17 | 3 | d6317843ae5c5749452889e768c187a9d9e8c7fe | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-05 | 163 | 17 | 3 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.29e-05 | 167 | 17 | 3 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.29e-05 | 167 | 17 | 3 | b89ebd4906f52b1fe6b6540ec9339284e7caddd2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 169 | 17 | 3 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 17 | 3 | 76caad53d55fff5acca27bf190a6de7b27437d9f | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 17 | 3 | fa5c3020e75fdde1363393dea97ebd99f1eae9ff | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.39e-05 | 184 | 17 | 3 | 1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.39e-05 | 184 | 17 | 3 | 2467207aaea307873ab286f89cfc7668a227a694 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 184 | 17 | 3 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 17 | 3 | 1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645 | |
| ToppCell | droplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.39e-05 | 184 | 17 | 3 | ad520ab6bb776b5303df505b7e1afb22484f18a7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.46e-05 | 185 | 17 | 3 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.60e-05 | 187 | 17 | 3 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.68e-05 | 188 | 17 | 3 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.75e-05 | 189 | 17 | 3 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 4.90e-05 | 191 | 17 | 3 | 86ce98d2c90c196474b06869de888cf5d1eed196 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 191 | 17 | 3 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-05 | 191 | 17 | 3 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.98e-05 | 192 | 17 | 3 | 6c089bde63dd5f16a07c5929fb49df600f0b21ab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.98e-05 | 192 | 17 | 3 | 694626965faee8b7c4e5bb78d554f62ba8dbc423 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 5.06e-05 | 193 | 17 | 3 | 2ffe44edf2b02d11a7c10513692eb697a10f911e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 194 | 17 | 3 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 194 | 17 | 3 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | proximal-Hematologic-Natural_Killer_T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-05 | 195 | 17 | 3 | 3944e4800f5d904d4efa401ce8913ec0e0781211 | |
| ToppCell | proximal-Hematologic-Natural_Killer_T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-05 | 195 | 17 | 3 | 4d7c2c4d0130c2d46877ff6dd4584525d8f74daf | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.21e-05 | 195 | 17 | 3 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | proximal-3-Hematologic-Natural_Killer_T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-05 | 195 | 17 | 3 | 93093545bb23d2619ace029a52cffa1f673a0c2a | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 5.29e-05 | 196 | 17 | 3 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.37e-05 | 197 | 17 | 3 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 5.45e-05 | 198 | 17 | 3 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | Caecum-T_cell-Treg|T_cell / Region, Cell class and subclass | 5.45e-05 | 198 | 17 | 3 | 90a2a75ca078f7088b8739795a9b396113bcbe23 | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 5.54e-05 | 199 | 17 | 3 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.54e-05 | 199 | 17 | 3 | 2ac716f887687b5109fb9feced75d5c62646a268 | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 5.54e-05 | 199 | 17 | 3 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 199 | 17 | 3 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 199 | 17 | 3 | 4b6d49b96bfcd6604b082bab620ae03276520885 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.54e-05 | 199 | 17 | 3 | aa6f1390283617c7f9aaf91d379024832ea24a9e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial|1m / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | fe15fb050852c187f6f17fb4f6172e69fe7d74a4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial-Proteoglycan-expressing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | d0a4c3bf9c5211defb4c1d0b6653833cccbd29ee | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-05 | 200 | 17 | 3 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 42 | 17 | 2 | 56bbec86001d43cc2c71d4dcd70b22ea41963fad | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-04 | 53 | 17 | 2 | c8af66760dac32cdbc0f17d1c004596c847f16f6 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-04 | 53 | 17 | 2 | d55030028f9ac970afb343ef6e1c41ab4bb2ae53 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Lypd1_(dSPN,_patch)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.93e-04 | 67 | 17 | 2 | 45228b2a1e445ecba32820a282088fd0c4bb2929 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Lypd1_(dSPN,_patch)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.93e-04 | 67 | 17 | 2 | 4fb4381133cfc3a2d5b633eea76c4fc4ef051f08 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.97e-04 | 78 | 17 | 2 | d5e2e2e04e380b265b2530e93cba6f98ad329e4f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl-Penk_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.49e-04 | 83 | 17 | 2 | b683c8496474b0df0042f596c9b0ea5916a2ab15 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.44e-04 | 107 | 17 | 2 | fc07dd90f280191bd643398eac5c8273651d0925 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.44e-04 | 107 | 17 | 2 | 4a18261492371d19b8dbd403e197fdf64ef69392 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Cd74|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.59e-04 | 115 | 17 | 2 | 4c7d78a246f1b44846fb959359515ef185530053 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 116 | 17 | 2 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-04 | 117 | 17 | 2 | 5a23770806b4612bed4ae6fd716abdec7f7f56c6 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-2|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 9.50e-04 | 121 | 17 | 2 | a74f530abc7295bed3e73b37ef47fcb04b0dcc6e | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.66e-04 | 122 | 17 | 2 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-03 | 126 | 17 | 2 | 28fbe63f7bc628b32d8e86bf9e80657e776dd1cc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-03 | 126 | 17 | 2 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.05e-03 | 127 | 17 | 2 | 508b188ccbe5aa6ec0128c443aedb5a8ea35a6d0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-03 | 130 | 17 | 2 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-03 | 130 | 17 | 2 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.11e-03 | 131 | 17 | 2 | 308ddb7fe113eac5dbeb9cb0b688d9e09275ce5e | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.13e-03 | 132 | 17 | 2 | 06e7337de35bd7120655a22b6020604ad004c4e1 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 137 | 17 | 2 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 137 | 17 | 2 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-03 | 138 | 17 | 2 | cd2f4682fcfd0275ce0640150bbb18da839e5c0a | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.23e-03 | 138 | 17 | 2 | 97f5dc17522462133e582b508ad0ef036e656872 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-03 | 140 | 17 | 2 | 9f105687f5749399fd76043fd85da58be30f2caf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-03 | 140 | 17 | 2 | a3be1fb7d2eb44bc123456d03250502938d46d9d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-03 | 141 | 17 | 2 | b5e85f89b930a0ec70cc95733c5ab76ac3e9497f | |
| ToppCell | Mild/Remission-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.30e-03 | 142 | 17 | 2 | fc5fc2d2b4b976358b8ce762c1f440b20db84103 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.34e-03 | 144 | 17 | 2 | 1c118b22c2ff3a526a5207d6c9d772636ee065fd | |
| ToppCell | mild_COVID-19_(asymptomatic)-Treg|World / disease group, cell group and cell class (v2) | 1.36e-03 | 145 | 17 | 2 | a3b0e1d0ce0caa8b281a146439d6455db64cc3e5 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 1.36e-03 | 145 | 17 | 2 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-03 | 145 | 17 | 2 | 29422c908d58081e6a748e362a7ac41bf001444c | |
| ToppCell | mild_COVID-19_(asymptomatic)-Treg|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.36e-03 | 145 | 17 | 2 | 2d0903009e918500facfd017ff31f2cec1e76131 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-03 | 147 | 17 | 2 | 48d72b6770cd029dd299676e5d83e6ac62102049 | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.42e-03 | 148 | 17 | 2 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.43e-03 | 149 | 17 | 2 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-03 | 149 | 17 | 2 | 13b445c13bb8f31ff0876addd1baf969ae220ea3 | |
| Drug | AR18 | 5.24e-06 | 5 | 17 | 2 | CID000114011 | |
| Drug | 6-chloro-6-deoxymannose | 1.88e-05 | 9 | 17 | 2 | CID000021090 | |
| Drug | beta-hydroxy simvastatin acid | 2.54e-05 | 78 | 17 | 3 | ctd:C483161 | |
| Drug | didox | 3.06e-05 | 83 | 17 | 3 | CID000003045 | |
| Drug | aluminum fluoride | 3.96e-05 | 268 | 17 | 4 | CID000002124 | |
| Drug | AC1L22RD | 4.03e-05 | 91 | 17 | 3 | CID000065183 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 7.33e-05 | 314 | 17 | 4 | CID000447989 | |
| Disease | heart disease (implicated_via_orthology) | 1.92e-04 | 38 | 16 | 2 | DOID:114 (implicated_via_orthology) | |
| Disease | asthma | 7.18e-03 | 751 | 16 | 3 | MONDO_0004979 | |
| Disease | aortic measurement | 7.99e-03 | 251 | 16 | 2 | EFO_0020865 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NIGFKVNSKKMLGKY | 351 | Q5FVE4 | |
| NMGLVKQCLSSLYKK | 291 | Q9UNS2 | |
| CNKYCKMLGLKSLQN | 2121 | Q86TB3 | |
| KYICMNKRGKLIGKP | 106 | O60258 | |
| FRGNMQKKCYGKIKA | 731 | Q9UBC5 | |
| PKLGANMKKLENCNY | 451 | P13797 | |
| KSYLMNKLAGKKNGF | 51 | P32456 | |
| KSYLMNKLAGKNKGF | 51 | Q9H0R5 | |
| KSYLMNKLAGKNKGF | 51 | Q96PP8 | |
| KSYLMNKLAGKNKGF | 51 | Q8N8V2 | |
| KYLMKSCKNLKGGLQ | 196 | Q9UIV1 | |
| KGKAFSNKKYLGLQM | 371 | P83105 | |
| LCYKLLKKLQMENNG | 706 | Q9UBT7 | |
| MKIKTGKALNLGYAL | 906 | P12111 | |
| KYLMKSCKNLKGGLQ | 196 | Q9UFF9 | |
| DCYQSKLKGKLMPNL | 216 | Q9GZT4 | |
| KLCKGMFTKKLGNTN | 16 | Q8NB66 |